150 related articles for article (PubMed ID: 1325358)
1. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
Stapelfeld A; Hammond DL; Rafferty MF
Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
[TBL] [Abstract][Full Text] [Related]
2. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
3. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
[TBL] [Abstract][Full Text] [Related]
4. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of swim-stress-induced antinociception by the delta-opioid receptor antagonist naltrindole in adult and young rats.
Kitchen I; Pinker SR
Br J Pharmacol; 1990 Aug; 100(4):685-8. PubMed ID: 2169936
[TBL] [Abstract][Full Text] [Related]
6. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
Crook TJ; Kitchen I; Hill RG
Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
[TBL] [Abstract][Full Text] [Related]
7. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice.
Smith FL; Dewey WL
J Pharmacol Exp Ther; 1992 Sep; 262(3):995-1003. PubMed ID: 1326632
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
9. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
[TBL] [Abstract][Full Text] [Related]
10. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
Watkins LR; Wiertelak EP; Maier SF
Brain Res; 1992 Jun; 582(1):10-21. PubMed ID: 1323369
[TBL] [Abstract][Full Text] [Related]
11. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
[TBL] [Abstract][Full Text] [Related]
13. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
14. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
15. The effect of the leucopyrokinin analogue: [2-8]-leucopyrokinin on central opioid receptors in rats.
Rykaczewska-Czerwińska M; Konopińska D; Plech A
Comp Biochem Physiol C Toxicol Pharmacol; 2001 Nov; 130(3):271-9. PubMed ID: 11701384
[TBL] [Abstract][Full Text] [Related]
16. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH
Eur J Pharmacol; 1992 May; 216(1):97-101. PubMed ID: 1326441
[TBL] [Abstract][Full Text] [Related]
17. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Song ZH; Takemori AE
Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
[TBL] [Abstract][Full Text] [Related]
18. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
Song ZH; Takemori AE
J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
[TBL] [Abstract][Full Text] [Related]
19. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
